Looking In On Lantheus Holdings

Sep. 14, 2022 1:16 PM ETLantheus Holdings, Inc. (LNTH)PGNX19 Comments


  • Today, we put the spotlight on Lantheus Holdings for the first time.
  • The stock has been a big winner in 2022 thanks to the impressive growth racked up by recently launched imaging agent Pylarify.
  • Can the good times continue for shareholders? An investment analysis follows in the paragraphs below.
  • Looking for a portfolio of ideas like this one? Members of The Biotech Forum get exclusive access to our model portfolio. Learn More »

Hispanic woman working on computer. Female doctor analyzing medical scan result.

vm/E+ via Getty Images

Never put off till tomorrow what may be done day after tomorrow just as well.”― Mark Twain

Today, we take our first look at Lantheus Holdings (NASDAQ:NASDAQ:LNTH). I had a decent sized position in

Stock Chart

Seeking Alpha

Pylarify Q2 sales

August Company Presentation


August Company Presentation

Product Portfolio

August Company Presentation

Forward Guidance

August Company Overview

Balance Sheet

August Company Presentation


August Company Presentation

DEFINITY Potential Market

August Company Overview

Other Imaging Agent Development

August Company Presentation

Live Chat on The Biotech Forum has been dominated by discussion of lucrative buy-write or covered call opportunities on selected biotech stocks over the past several months. To see what I and the other season biotech investors are targeting as trading ideas real-time, just join our community at The Biotech Forum by clicking HERE.

This article was written by

Bret Jensen profile picture
Finding tomorrow's big winners in the lucrative biotech sector

Finding tomorrow's big winners in the lucrative biotech sector, The Biotech Forum focuses on proprietary, breaking research on promising biotech and biopharma stocks with significant potential for outsized alpha. It is the fourth most subscribed to investment service offered through the Marketplace on SeekingAlpha.com. Our service offers a model-20 stock portfolio as well as the most active Live Chat on the Marketplace. This is where scores of seasoned biotech investors trade news and investment ideas back and forth throughout the trading day.

• • •

Specializing in profiling high beta sectors, Bret Jensen founded and also manages The Biotech Forum, The Insiders Forum, and the Busted IPO Forum model portfolios. Finding “gems” in the biotech and small-cap stock sectors, these highly volatile spaces proven hugely successful have empowered Bret Jensen's own investing portfolio.

• • •

Learn more about Bret Jensen's Marketplace Offerings:

The Insiders Forum | The Biotech Forum | Busted IPO Forum

Disclosure: I/we have a beneficial long position in the shares of LNTH either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Recommended For You

Comments (19)

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.